Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their Prodrugs is a research paper published in ACS Pharmacology & Translational Science (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: ZIA BC005562
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: ZIADK31117
Intramural NIH HHS
Grant: ZIA DK031117
Intramural NIH HHS
Grant: Z01 BC005562
FWCI
0.66
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals